Proteasome-mediated degradation of transcriptional activators correlates with activation domain potency in vivo
Open Access
- 15 November 1999
- journal article
- research article
- Published by Springer Nature in The EMBO Journal
- Vol. 18 (22), 6439-6447
- https://doi.org/10.1093/emboj/18.22.6439
Abstract
We show that the intracellular concentration of transcriptional activator proteins is regulated by the proteasome‐mediated protein degradation pathway. The rate of degradation of activators by proteasomes correlates with activation domain potency in vivo . Mutations either in the activation domain residues involved in target protein interaction or in the DNA‐binding domain residues essential for DNA binding abolish the transcriptional activation function in vivo and render the activator resistant to degradation by proteasomes. Finally, using a rapamycin‐regulated gene expression system, we show that recruiting activation domains to DNA‐bound receptor proteins greatly enhanced the rate of degradation of reconstituted activators. These observations suggest that in mammalian cells efficient recruitment of activator–target protein complexes to the promoter means that they are subjected to rapid degradation by proteasomes. We propose that proteasome‐mediated control of the intracellular levels of transcriptional activators could play an important role in the regulation of gene expression.Keywords
This publication has 62 references indexed in Scilit:
- Rel/NF-κB and IκB proteins: an overviewSeminars in Cancer Biology, 1997
- Transcriptional activation by recruitmentNature, 1997
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Stimulation of RNA polymerase II transcription initiation by recruitment of TBP in vivoNature, 1995
- Connecting a promoter-bound protein to TBP bypasses the need for a transcriptional activation domainNature, 1995
- Interaction with RAP74 subunit of TFIIF is required for transcriptional activation by serum response factorNature, 1995
- Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.Genes & Development, 1994
- The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53Cell, 1993
- Negative effect of the transcriptional activator GAL4Nature, 1988
- The c-fos serum response element responds to protein kinase C-dependent and -independent signals but not to cyclic AMP.Genes & Development, 1988